Google
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Management During the Blood Crisis With Edward Ivy, MD, MPH
In January, The American Red Cross reported that it was facing “its worst blood shortage in over a decade” amid surging cases of the Omicron COVID-19 virus. For the first time since its inception, the Red Cross declared a “Blood Crisis”, with blood and platelet donations reaching critically low levels.
Among the patients in dire need of blood transfusions such as accident victims and cancer patients are patients with sickle cell disease. Approximately 100,000 cases of sickle cell disease have been recorded in United States, and the current blood shortage could prove dangerous to those affected.
Edward Ivy, MD, MPH, Vice Chief Medical Officer of the Sickle Cell Association of America (SCDAA), spoke of the implications of the blood shortage for patients with sickle cell disease in a wide-ranging interview with HCPLive.
+myBinderRelated Content
-
First systemic evidence for safety of tPA in stroke patients with sickle cell diseaseIn the largest report on acute stroke in...
-
Cardiomyopathy With Restrictive Physiology in Sickle Cell DiseaseOBJECTIVES: The aim of this study was to...
-
Today’s Faces of Sickle Cell Disease: Carolyn Rowley, PhDCarolyn Rowley is a psychologist, patien...
-
SCDAA Masterclass Speaker Series: All Things Considered – SCD Treatment: A Personal ChoiceSCDAA's First Masterclass on the Cusp of...
-
Steven Hardy, PhDSteven Hardy, Ph.D. is the Director of P...
-
Melissa Claar, MA, RN, CPNPNurse Practitioner Melissa Claar, MA, RN...
-
GBT expands sickle cell disease pipeline with worldwide licensing agreement for inclacumab for the treatment of vaso...Global Blood Therapeutics, Inc...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.